Mesenchymal stem cells as vehicles for gene delivery

Area of Science:

• * Regenerative Medicine
• * Gene Therapy
• * Stem Cell Biology

Background:

• * Mesenchymal stem cells (MSCs) are crucial for regenerating various connective tissues.
• * Transducing non-human MSCs is vital for developing disease models for MSC-based gene delivery.
• * Previous attempts faced challenges with amphotropic retroviral vectors for certain species.

Purpose of the Study:

• * To compare the efficacy of different retroviral vectors (amphotropic, xenotropic, gibbon-ape leukemia virus) for transducing MSCs from various species.
• * To evaluate the biodistribution and potential of gene-marked MSCs for marrow stromal regeneration in a canine model.

Main Methods:

• * Comparative transduction of human, baboon, canine, rat, sheep, goat, pig, and rabbit MSCs with amphotropic, xenotropic, and gibbon-ape leukemia virus envelope-pseudotyped retroviral vectors.
• * In vivo biodistribution study using gene-marked canine MSCs in a myeloablative canine transplantation model.

Main Results:

• * Optimal transduction varied by species: amphotropic for human, baboon, canine, rat; xenotropic for sheep, goat, pig; gibbon-ape for rabbit.
• * Transduced canine MSCs were predominantly found in bone marrow samples post-infusion.
• * Demonstrated successful delivery of MSCs to the marrow compartment.

Conclusions:

• * Different retroviral vectors are required for efficient MSC transduction across species.
• * Mesenchymal stem cells are a viable delivery vehicle for gene transfer.
• * MSC delivery to the bone marrow compartment supports stromal regeneration, particularly after cytotoxic therapies.